{"count":6,"items":[{"article":null,"cancer_slugs":["pan-cancer"],"category":"pathology","confidence":"medium","developer":"Paige / Memorial Sloan Kettering Cancer Center","hf":{"downloads":110111,"fetched_at":"2026-09-09T21:33:08Z","gated":"auto","last_modified":"2024-10-26","library":"timm","license":"cc-by-nc-nd-4.0","likes":151,"pipeline_tag":"image-feature-extraction"},"kind":"foundation","license":"cc-by-nc-nd-4.0","links":{"demo":null,"docs":null,"doi":null,"github":null,"huggingface":"https://huggingface.co/paige-ai/Virchow2","paper":"https://arxiv.org/abs/2408.00738","pmid":null},"modalities":["histopathology"],"name":"Virchow2","openness":"gated-weights","regulatory_status":"research-only","release_date":"2024-08-01","settings":["basic-research","diagnosis"],"slug":"virchow2","summary":"Successor to Virchow: ViT-H/14 pretrained on 3.1 million whole-slide images from about 225,000 patients across 45 countries, at mixed magnifications (5\u00d7\u201340\u00d7), with pathology-specific augmentations.","tasks":["feature-extraction","classification","detection"],"url":"/ai-oncology/models/virchow2","verified_at":"2026-09-05T22:26:01.142049","version":null},{"article":null,"cancer_slugs":["pan-cancer"],"category":"pathology","confidence":"high","developer":"Mahmood Lab, Brigham and Women's Hospital / Harvard Medical School","hf":{"downloads":40388,"fetched_at":"2026-09-09T21:33:08Z","gated":"auto","last_modified":"2025-03-06","library":"timm","license":"cc-by-nc-nd-4.0","likes":372,"pipeline_tag":"image-feature-extraction"},"kind":"foundation","license":"cc-by-nc-nd-4.0","links":{"demo":null,"docs":null,"doi":"10.1038/s41591-024-02857-3","github":"https://github.com/mahmoodlab/UNI","huggingface":"https://huggingface.co/MahmoodLab/UNI","paper":"https://www.nature.com/articles/s41591-024-02857-3","pmid":null},"modalities":["histopathology"],"name":"UNI","openness":"gated-weights","regulatory_status":"research-only","release_date":"2024-03-19","settings":["basic-research","diagnosis","prognosis"],"slug":"uni","summary":"General-purpose self-supervised vision encoder for H&E histopathology tiles, pretrained on more than 100 million tiles from over 100,000 whole-slide images; the reference foundation model for pathology feature extraction.","tasks":["feature-extraction","classification","detection","prognosis"],"url":"/ai-oncology/models/uni","verified_at":"2026-09-05T22:26:01.084174","version":"UNI (v1)"},{"article":null,"cancer_slugs":["pan-cancer"],"category":"pathology","confidence":"high","developer":"Paige / Memorial Sloan Kettering Cancer Center","hf":{"downloads":7616,"fetched_at":"2026-09-09T21:33:08Z","gated":"auto","last_modified":"2024-09-03","library":"timm","license":"apache-2.0","likes":76,"pipeline_tag":"image-feature-extraction"},"kind":"foundation","license":"cc-by-nc-nd-4.0","links":{"demo":null,"docs":null,"doi":"10.1038/s41591-024-03141-0","github":null,"huggingface":"https://huggingface.co/paige-ai/Virchow","paper":"https://www.nature.com/articles/s41591-024-03141-0","pmid":null},"modalities":["histopathology"],"name":"Virchow","openness":"gated-weights","regulatory_status":"research-only","release_date":"2024-07-22","settings":["diagnosis","basic-research"],"slug":"virchow","summary":"632-million-parameter vision transformer pretrained on 1.5 million whole-slide images from about 100,000 patients \u2014 the largest pathology pretraining set at its release \u2014 and used to build a pan-cancer detection model covering 17 cancer types, including rare ones.","tasks":["feature-extraction","classification","detection"],"url":"/ai-oncology/models/virchow","verified_at":"2026-09-05T22:26:01.133062","version":"Virchow (v1)"},{"article":null,"cancer_slugs":["prostate"],"category":"pathology","confidence":"high","developer":"Paige","hf":null,"kind":"product","license":"proprietary","links":{"demo":null,"docs":"https://www.accessdata.fda.gov/cdrh_docs/pdf20/DEN200080.pdf","doi":null,"github":null,"huggingface":null,"paper":null,"pmid":null},"modalities":["histopathology"],"name":"Paige Prostate Detect","openness":"closed","regulatory_status":"fda-de-novo","release_date":"2021-09-21","settings":["diagnosis"],"slug":"paige-prostate","summary":"The first AI software for pathology authorised by the US FDA (De Novo, September 2021): flags prostate biopsy whole-slide images likely to contain cancer so the pathologist reviews the suspicious region.","tasks":["detection","classification"],"url":"/ai-oncology/models/paige-prostate","verified_at":"2026-09-07T07:06:50.537219","version":null},{"article":null,"cancer_slugs":["invasive-breast-carcinoma"],"category":"screening","confidence":"medium","developer":"Kheiron Medical Technologies (now part of DeepHealth / RadNet)","hf":null,"kind":"product","license":"proprietary","links":{"demo":null,"docs":null,"doi":null,"github":null,"huggingface":null,"paper":null,"pmid":null},"modalities":["mammography"],"name":"Mia","openness":"closed","regulatory_status":"ce-marked","release_date":null,"settings":["screening"],"slug":"mia","summary":"Commercial AI reader for screening mammography, evaluated as an additional reader in the UK's double-reading pathway; the GEMINI prospective study in Aberdeen reported extra cancers found when Mia flagged cases the readers had cleared.","tasks":["screening","detection"],"url":"/ai-oncology/models/mia","verified_at":"2026-09-07T15:01:52.837241","version":null},{"article":null,"cancer_slugs":["invasive-breast-carcinoma"],"category":"screening","confidence":"medium","developer":"ScreenPoint Medical","hf":null,"kind":"product","license":"proprietary","links":{"demo":null,"docs":"https://screenpoint-medical.com/","doi":null,"github":null,"huggingface":null,"paper":null,"pmid":null},"modalities":["mammography"],"name":"Transpara","openness":"closed","regulatory_status":"fda-cleared","release_date":null,"settings":["screening"],"slug":"transpara","summary":"Commercial mammography AI with FDA clearance and CE marking, used as a concurrent or replacement reader in breast screening; the MASAI randomised trial in Sweden used it to triage screening reads.","tasks":["screening","detection"],"url":"/ai-oncology/models/transpara","verified_at":"2026-09-06T02:56:17.920346","version":null}],"standard":"https://cancer3.ai/docs/ai-model-card","vocab":{"confidence":["high","medium","low"],"dataset_access":["open","registration","dua","controlled","commercial"],"dataset_kinds":["dataset","registry","benchmark","biobank","corpus"],"formats":["SVS","TIFF","NDPI","DICOM","NIfTI","PNG","JPEG","CSV","TSV","JSON","Parquet","FASTQ","BAM","VCF","MAF","h5ad","PDB","mmCIF","text","other"],"kinds":["foundation","task-model","tool","framework","product"],"link_roles":["pretraining","training","finetuning","evaluation","benchmark"],"modalities":["histopathology","radiology-ct","radiology-mri","radiology-xray","mammography","pet","ultrasound","dermoscopy","endoscopy","genomics","transcriptomics","single-cell","proteomics","protein-sequence","molecules","clinical-text","literature","ehr","multimodal","immunopeptidomics"],"need_status":["open","in-progress","solved"],"openness":["open-weights","gated-weights","api-only","closed"],"regulatory":["research-only","fda-cleared","fda-de-novo","fda-pma","ce-marked","ce-ivdr","not-applicable"],"settings":["basic-research","screening","diagnosis","prognosis","treatment-planning","treatment-response","drug-discovery","clinical-trials","education","vaccine-design","immunotherapy"],"tasks":["feature-extraction","classification","segmentation","detection","screening","risk-prediction","prognosis","treatment-response","survival-analysis","image-text-retrieval","report-generation","question-answering","information-extraction","clinical-trial-matching","protein-structure","variant-effect","gene-expression","single-cell","drug-discovery","drug-repurposing","peptide-mhc-binding","antigen-presentation","neoantigen-prioritisation"]}}
